Clearance Summary
Smart Scope® CX received FDA 510(k) clearance under submission number K233043, sponsored by Periwinkle Technologies Pvt., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Obstetrics/Gynecology review panel. The statutory decision date of record is 2024-06-14.
- Submission: K233043
- Applicant / Sponsor: Periwinkle Technologies Pvt., Ltd.
- Clearance pathway: Traditional
- Review panel: Obstetrics/Gynecology
- Device class: Class II
- Regulation citation: 21 CFR 884.1630
- Decision date: 2024-06-14
Classification & Regulation
This clearance is catalogued under FDA product code HEX and 21 CFR 884.1630, within the Obstetrics/Gynecology review panel as a Class II device.